Sir, Toric posterior chamber (in-the-bag) intraocular lens implantation to correct postpenetrating keratoplasty astigmatism Postkeratoplasty astigmatism is a cause of significant visual impairment and can be difficult to treat satisfactorily. Treatment options include compression sutures, astigmatic keratotomy, targeted suture removal, hard contact lens wear, excimer laser photoablation, and toric intraocular lenses. This is the first United Kingdom report of the use of a toric posterior chamber intraocular lens used to correct this type of astigmatism.
lidocaine 0.5%). Preoperatively, the cornea was marked at the 3 and 9 o'clock meridians (0 and 1801) with tissue ink applied with a Sinskey hook. This was performed with the patient upright to avoid the torsional effects that can be encountered when patients are supine. The steep axis (1701) was marked using a two-bladed axis marker and a Mendez degree gauge. A 2.5 mm clear corneal incision was made at 1201, through which standard phacoemulsification was performed. The incision was placed at this meridian to suit a right-handed surgeon operating from the top of the operating table. The importance of complication-free surgery and in-the-bag placement of the implant outweighed the limited amount of astigmatism that could be corrected by operating on axis. The incision was enlarged to 3.5 mm and a foldable toric intraocular lens was inserted and placed in the bag with the axis of the cylinder carefully aligned to the 170 meridian. A single 10/0 nylon suture was placed in the corneal section that was removed 2 weeks later. No complications were encountered pre-or postoperatively. Postoperative refraction, 5 weeks after surgery and 3 weeks after the removal of the corneal suture, revealed reduction of her astigmatism: she achieved 6/7.5 vision with correction of À1.50/ þ 3.00 Â 10. Her optician later found and prescribed À0.75/ þ 1.25 Â 20.
Comment
The reduction of astigmatism achieved by a toric intraocular lens gives a best-corrected (spectacle) visual acuity (BCVA) of 6/7.5. The risks to the eye of combating astigmatism in this manner are no greater than for cataract surgery in any eye that has undergone corneal transplantation.
There are theoretical concerns regarding endothelial cell population damage, graft failure, and rejection in cataract surgery following PKP. A recent paper by Nagra et al 1 reviewed 29 eyes of 24 patients that underwent cataract surgery after PKP. Twenty-three of these eyes underwent phacoemulsification. They encountered one instance of graft failure (3%) in an eye that had three previous episodes of endothelial rejection. The degree of postoperative endothelial cell loss was not commented upon, but preoperative cell counts varied from 576 to 3344 cells/mm 2 with no apparent predictive effect on graft clarity or survival (all the eyes that had cell counts measured preoperatively did well).
There is also the theoretical risk that the implant can rotate and the angle of the corrective cylinder can change as a result-leading to ametropia. The serrated Z design haptic of the intraocular lens is designed to prevent this ( Figure 2) . Placement of the intraocular lens in the bag and subsequent fibrosis of the residual capsule should provide stability. There is always a risk of posterior capsular rupture at cataract surgery but in the hands of an experienced surgeon this is minimal. This particular toric IOL is not designed for sulcus placement and this hypothetical problem has not been encountered in our practice. Toric intraocular lens placement in the sulcus is described for correction of astigmatism in keratoconus 2 and sulcus toric intraocular lenses are available from HumanOptics (Mannheim, Germany).
Toric intraocular lens implantation to correct astigmatism can be divided into the phakic and pseudophakic groups. The toric phakic intraocular lens European multicenter study 3 was published in 2003 and assessed the use of iris clip intraocular lenses to correct up to 7.25 D of astigmatism in 70 eyes. Six-month data were presented and longer term follow-up is required. The same iris fixed lenses have also been used to correct myopia with results similar or better to LASIK. 4 In the context of postkeratoplasty astigmatism, Nujits et al 5 used the same lens in 16 eyes of 16 patients to treat postgraft astigmatism of up to 10 D. The authors reviewed eight other series of postgraft astigmatism treated with LASIK (138 eyes) and concluded that their 91721% reduction of astigmatism is superior to that achieved by LASIK. Uncorrected visual acuity of 6/12 or better was achieved in 50% of patients who received a toric phakic IOL. Anterior chamber iris fixated lenses raise theoretical concerns about cystoid macula oedema, inflammation, glaucoma, and endothelial cell loss. In this series, endothelial cell loss was 15.277.6% at 6 months which compares with a natural wastage of 7.8% in the first 3-5 years postkeratoplasty. LASIK is another modality used to correct post-PKP astigmatism. A recent series of 57 eyes that underwent corrective LASIK following PKP was reported by Hardten et al. 13 Preoperatively, BCVA of 6/12 or better was noted in 74%. One year postoperatively, 75% achieved this level of vision with correction and 38% unaided. Mean astigmatism reduced from 4.6772.18 to 1.9471.35 D. Nine per cent required retreatment and 16% developed epithelial ingrowth. The level of astigmatism in our patient was more than this and LASIK would have been unlikely to achieve the desired effect.
Posterior chamber implantation of a toric intraocular lens can provide a very good refractive outcome in the context of post-PKP astigmatism. The requisite surgical intervention is safe with few side effects and is unlikely to have any significant impact on graft rejection or survival.
